Associate Professor David Elliott leads the Heart Disease group at the Murdoch Children's Research Institute (MCRI) and he is a principal investigator of the Novo Nordisk Foundation for Stem Cell Medicine (reNEW). David co-directs, with Associate Professor Rachel Conyers, the Australian Cardio-Oncology Registry (ACOR), a national program targeted at improving long-term cardiac health outcomes for childhood cancer survivors. The focus of Associate Professor Elliott’s laboratory is to develop pluripotent stem cell-based models of heart disease and use these models to find new therapies for heart disease. Throughout his career Assoc. Prof. Elliott has made important contributions to understanding the molecular control of heart muscle development, function and disease.
Associate Professor David Elliott completed his PhD on the genetics of heart development at The Victor Chang Cardiac Research Institute and The Walter and Eliza Hall Institute. He continued to post-doctoral studies at the University of Cambridge studying the nervous system in the fruit fly at the Wellcome Trust/Cancer Research UK Gurdon Institute. Associate Professor Elliott began using human pluripotent stem cells in a second post-doc with Professors Andrew Elefanty and Ed Stanley at Monash University where he generated key stem cell lines and identified the first cardiac lineage cell surface markers.
Associate Professor David Elliott leads the Heart Disease group at the Murdoch Children's Research Institute (MCRI) and he is a principal investigator of the Novo Nordisk Foundation for Stem Cell Medicine (reNEW). David co-directs, with Associate...
Associate Professor David Elliott leads the Heart Disease group at the Murdoch Children's Research Institute (MCRI) and he is a principal investigator of the Novo Nordisk Foundation for Stem Cell Medicine (reNEW). David co-directs, with Associate Professor Rachel Conyers, the Australian Cardio-Oncology Registry (ACOR), a national program targeted at improving long-term cardiac health outcomes for childhood cancer survivors. The focus of Associate Professor Elliott’s laboratory is to develop pluripotent stem cell-based models of heart disease and use these models to find new therapies for heart disease. Throughout his career Assoc. Prof. Elliott has made important contributions to understanding the molecular control of heart muscle development, function and disease.
Associate Professor David Elliott completed his PhD on the genetics of heart development at The Victor Chang Cardiac Research Institute and The Walter and Eliza Hall Institute. He continued to post-doctoral studies at the University of Cambridge studying the nervous system in the fruit fly at the Wellcome Trust/Cancer Research UK Gurdon Institute. Associate Professor Elliott began using human pluripotent stem cells in a second post-doc with Professors Andrew Elefanty and Ed Stanley at Monash University where he generated key stem cell lines and identified the first cardiac lineage cell surface markers.
Top Publications
Goulburn, AL, Alden, D, Davis, RP, Micallef, SJ, Ng, ES, Yu, QC, Lim, SM, Soh, C-L, Elliott, DA, Hatzistavrou, T, et al.
A targeted NKX2.1 human embryonic stem cell reporter line enables identification of human basal forebrain derivatives..
Stem Cells
29(3)
:
462 -473
2011
view publication
Chen, Q, Jin, L, Cook, WD, Mohn, D, Lagerqvist, EL, Elliott, DA, Haynes, JM, Boyd, N, Stark, WJ, Pouton, CW, et al.
Elastomeric nanocomposites as cell delivery vehicles and cardiac support devices.
Soft Matter
6(19)
:
4715 -4726
2010
view publication
Elliott, DA, Kirk, EP, Schaft, D, Harvey, RP.
Chapter 9.1 NK-2 Class Homeodomain Proteins Conserved Regulators of Cardiogenesis.
569 -597
2010
view publication
Southall, TD, Elliott, DA, Brand, AH.
The GAL4 System: A Versatile Toolkit for Gene Expression in Drosophila..
CSH Protoc
2008:
pdb.top49
2008
view publication
Elliott, DA, Brand, AH.
The GAL4 system : a versatile system for the expression of genes..
420:
79 -95
2008
view publication